Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Repair Inc.

Latest From Repair Inc.

Angioblast begins US stem cell trial for heart failure

Angioblast Systems has begun what it says is the first clinical trial with allogeneic stem cells for the treatment of serious heart failure.

Cardiovascular Orthopedics

Ikaria licenses cardiac therapy from BioLineRx

Ikaria has obtained a worldwide exclusive licence to BioLineRx’s BL-1040, a potential treatment for preventing cardiac damage following a heart attack, for up to $282.5 million.

Cardiovascular Israel

Cdn$94 million boost for genomics research in Ontario

Genomics research in Canada has received a Cdn$94 million ($51.5 million) boost from the Ontario government to support continued research in the area.

Canada

First advanced therapy, ChondroCelect, OKd in EU for knee damage

A cell-based medicine for repairing knee damage has become the first product to be recommended for approval by the European Medicines Agency under the EU's new advanced therapy regulatory framework.

Orthopedics Germany
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
UsernamePublicRestriction

Register